×
Nyxoah SA Total Long Term Liabilities 2021-2024 | NYXH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Nyxoah SA total long term liabilities from 2021 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
View More
Nyxoah SA Total Long Term Liabilities 2021-2024 | NYXH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Nyxoah SA total long term liabilities from 2021 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
Related Stocks
Company Name
Market
Cap
GE HealthCare Technologies (GEHC)
$40.4B
Tempus AI (TEM)
$7.9B
Inspire Medical Systems (INSP)
$6.2B
Axonics (AXNX)
$3.5B
Hims & Hers Health (HIMS)
$3.5B
10x Genomics (TXG)
$2.7B
Enovis (ENOV)
$2.4B
Azenta (AZTA)
$2.4B
Privia Health (PRVA)
$2.3B
IRhythm Technologies (IRTC)
$2.2B
Omnicell (OMCL)
$2B
Clover Health Investments (CLOV)
$1.5B
Schrodinger (SDGR)
$1.4B
Phreesia (PHR)
$1.4B
Standard BioTools (LAB)
$753M
Fulgent Genetics (FLGT)
$694M
Definitive Healthcare (DH)
$538M
Health Catalyst (HCAT)
$529M
Butterfly Network (BFLY)
$406M
Talkspace (TALK)
$343M
Pulmonx (LUNG)
$329M
SOPHiA GENETICS SA (SOPH)
$286M
TruBridge (TBRG)
$183M
P3 Health Partners (PIII)
$165M
American Well (AMWL)
$147M
Augmedix (AUGX)
$115M
EUDA Health Holdings (EUDA)
$90M
Future Health ESG (FHLT)
$65M
SHL Telemedicine (SHLT)
$55M
HeartBeam (BEAT)
$53M